title: Novel tumor-associated accessory molecules involved in the gamma/delta cytotoxic T-lymphocyte-Burkitt's lymphoma interaction.
abstract: BACKGROUND
  Tumor specific cytotoxic T lymphocytes (CTL) recognize antigen via the T-cell receptor (TCR). In addition, recognition requires accessory molecules involved in adhesion and signal transduction. The authors previously have characterized an autologous, Burkitt's lymphoma specific CTL line that uses the gamma-delta TCR to recognize antigen in a nonclassical context. The current study was undertaken to identify novel accessory molecules involved in this unusual TCR-tumor cell interaction.
  
  
  METHODS
  A panel of monoclonal antibodies was generated against a Burkitt's lymphoma cell line and was screened for inhibition of autologous, tumor specific, cytolysis by a gamma-delta CTL line. Proteins identified by these monoclonal antibodies were further characterized by fluorescent-activated cell sorter analysis, Western blot and immunoprecipitation.
  
  
  RESULTS
  Three known (CD5, CD43, and CD11a/CD18) and three novel (BAM-1, BAM-2, and BAM-3) cell surface molecules involved in the gamma-delta CTL-Burkitt's lymphoma interaction were identified and characterized.
  
  
  CONCLUSIONS
  This study identifies and provides a preliminary characterization of three novel Burkitt's lymphoma-associated molecules involved in the gamma-delta CTL-tumor cell interaction and demonstrates that CD5, CD43, and CD11a/CD18 are involved in this interaction. It is likely that other unidentified accessory molecules are also involved in this and other effector cell-tumor interactions. Identification of such molecules may be useful in the design of new immunotherapeutic approaches.
authors.affiliation: Department of Medicine, Stanford University School of Medicine, CA 94305.
authors.forename: E L
authors.initials: EL
authors.lastname: Nelson
authors.forename: H T
authors.initials: HT
authors.lastname: Kim
authors.forename: N D
authors.initials: ND
authors.lastname: Mar
authors.forename: T J
authors.initials: TJ
authors.lastname: Goralski
authors.forename: B W
authors.initials: BW
authors.lastname: McIntyre
authors.forename: C
authors.initials: C
authors.lastname: Clayberger
authors.forename: A M
authors.initials: AM
authors.lastname: Krensky
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis; D015703:Antigens, CD / Q000502:physiology; D000954:Antigens, Surface / Q000302:isolation & purification / Q000502:physiology*; D015153:Blotting, Western; D002051:Burkitt Lymphoma / Q000276:immunology*; D018956:CD5 Antigens; D005434:Flow Cytometry; D006801:Humans; D051917:Leukosialin; D016169:Lymphocyte Function-Associated Antigen-1 / Q000502:physiology; D051379:Mice; D008807:Mice, Inbred BALB C; D011233:Precipitin Tests; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000276:immunology*; D012795:Sialoglycoproteins / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000954:Antigens, Surface; D018956:CD5 Antigens; D051917:Leukosialin; D016169:Lymphocyte Function-Associated Antigen-1; D016692:Receptors, Antigen, T-Cell, gamma-delta; C465014:SPN protein, human; D012795:Sialoglycoproteins; C497863:Spn protein, mouse